A bibliometric analysis of 394 publications reveals a substantial gap between computational publication output and clinical validation evidence, and the research paradigm remains primarily methodology-driven rather than clinically anchored.
Abstract
Background Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer and the one with the fewest therapeutic targets. The application of machine learning (ML) in TNBC research is becoming increasingly widespread; however, systematic bibliometric studies focusing on this rapidly evolving interdisciplinary field are still lacking. Methods This study systematically searched the Web of Science Core Collection and Scopus databases for relevant literature on the application of ML in the field of TNBC published between January 2011 and January 2026. These publications were analyzed using VOSviewer, CiteSpace, and the R/Bibliometrix package. An independent external validation was conducted using the same search strategy in the PubMed database. Additionally, clinical trials and randomized controlled trials were identified through PubMed to quantify the clinical translation gap in this field. Results We conducted a bibliometric analysis of 394 publications and found that global publication output exhibits a nonlinear growth trend. China ranked first in publication volume with 180 papers, while the United States ranked first in academic influence with an average of 39.09 citations per paper; the collaboration network revealed a global pattern with China and the United States as dual hubs. Co-occurrence analysis of keywords identified six major thematic clusters, broadly corresponding to three domains: disease understanding, methodological innovation, and clinical translation. Citation emergence analysis revealed that “deep learning,” “radiomics,” and “tumor-infiltrating lymphocytes” represent the most robust emerging frontiers at present. Cluster analysis of co-cited literature identified three dominant research themes: prognostic prediction models, radiomic diagnosis, and multi-omics integration. External validation results from PubMed showed high consistency with the main analysis; however, the clinical translation gap analysis revealed a 16:1 retrospective-validation-to-development ratio (24 retrospective validation studies versus 394 development studies) and a 44:1 prospective-trial-to-development ratio (9 registered trials versus 394 development studies). No prospective interventional trials were identified. Conclusion Research on machine learning in the field of triple-negative breast cancer (TNBC) is currently undergoing rapid expansion, with current research hotspots centered on radiomics, deep learning, and the discovery of multi-omics biomarkers. However, clinical validation remains scarce: only 24 retrospective validation studies (6.1%) and 9 registered trials (2.3%) were identified relative to 394 computational development studies. Our bibliometric analysis reveals a substantial gap between computational publication output and clinical validation evidence, and the research paradigm remains primarily methodology-driven rather than clinically anchored. Multicenter, prospective clinical trials with patient-centered endpoints are needed to bridge this structural translation gap.
Triple-negative breast cancer (TNBC) is an aggressive and heterogeneous breast cancer subtype for which artificial intelligence (AI) is increasingly being investigated across diagnostic, prognostic, and treatment response applications. This study presents a comparative bibliometric analysis of AI-related TNBC researc...
M. Shenoy, R. Shetty, Sidhant Gupta et al.· Discover Applied Sciences· 0 citations
Artificial intelligence research in pancreatic cancer is growing rapidly and becoming increasingly multidisciplinary, although productivity and collaboration remain uneven.
Pegah Rashidian, A. Smerat, Mohammad Ahmar Khan et al.· Medicine· 0 citations
Early detection of breast cancer recurrence risk is critical for informing treatment decisions and providing personalized patient care. Recent advancements in machine learning (ML) and deep learning (DL) have enabled the development of predictive models that can leverage diverse clinical, imaging, and molecular dataset...
This manuscript reports the protocol, conceptual framework, and methodology for a systematic review that updates and extends the prior evidence synthesis, focusing on studies published between September 2023 and August 2026 that apply ML techniques to breast cancer prediction under conditions of class imbalance.
Omega John Unogwu, Andrea Ngohide Abaagu, Ankar Tersoo Catherine· EDRAAK· 0 citations
Aims: Thyroid cancer is a foundational model for theranostics, integrating targeted diagnosis and therapy through common biological markers. This study evaluates the scientific evolution, collaboration networks, and thematic structure of thyroid cancer theranostics using bibliometric and science mapping methods.Methods...
H. Ozcevik· Journal of Health Sciences a...· 0 citations
Artificial intelligence models integrate molecular omics to reproduce breast cancer subtype labels or discover patient groups, but heterogeneous endpoints, cohorts, and validation hinder interpretation. We searched PubMed/MEDLINE, Europe PMC, and OpenAlex through 2026 September 8, supplemented by citation searching and...
Deepali Pilodiya, A. N. Hoshyar, Cameron Foale et al.· Computational and Structural...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.